Trial | NCT01684475  Report issue

Title

A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE
A STUDY TO EVALUATE THE EFFICACY OF CJH1 [CLR4001] IN THE TREATMENT OF PARKINSON'S DISEASE

  • Phase

    Phase 1/Phase 2

  • Study Type

    Interventional

  • Status

    Unknown status

  • Intervention/Treatment

    cjh1 ...

  • Study Participants

    21
The purpose of this study is to assess the ability of CJH1 to increase the sensitivity of dopamine receptors and thereby reduce symptoms of Parkinson's Disease.
Study Started
Sep 30
2012
Primary Completion
Sep 30
2013
Study Completion
Sep 30
2013
Anticipated
Last Update
Sep 13
2012
Estimate

Drug CJH1 (CLR4001)

Treatment with CJH1 Experimental

Criteria 

Inclusion Criteria:

Patient's with Parkinson's disease

Exclusion Criteria:

Contraindications to study medication
No Results Posted